Hepion Pharmaceuticals
HEPA
#10815
Rank
C$20.97 M
Marketcap
C$0.17
Share price
3.22%
Change (1 day)
72.57%
Change (1 year)

Earnings for Hepion Pharmaceuticals (HEPA)

Earnings in 2026 (TTM): -C$10.57 Million

According to Hepion Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$18.72 Million, an increase over its 2024 earnings that were of -C$22.3 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hepion Pharmaceuticals from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$10.57 Million-43.55%
2025 -C$18.72 Million-16.06%
2024 -C$22.3 Million-68.5%
2023 -C$70.81 Million9.74%
2022 -C$64.53 Million37.49%
2021 -C$46.93 Million61.27%
2020 -C$29.1 Million174.55%
2019 -C$10.6 Million-31.28%
2018 -C$15.43 Million
2016 -C$30.62 Million6.03%
2015 -C$28.87 Million265%
2014 -C$7.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.23 Billion 1,940.94%๐Ÿ‡บ๐Ÿ‡ธ USA